Beat AML Core Study
Cellworks Group Inc.
University of Florida

      In this study, DNA sequencing, computational biology modeling, and ex vivo drug sensitivity
      assays will be utilized to define clinically relevant gene mutations and identify potential
      therapeutics for patients with acute myeloid leukemia (AML).
    
Genetic